# PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

> **NCT01178502** · — · COMPLETED · sponsor: **Inje University** · enrollment: 405 (actual)

## Conditions studied

- Heart Valve Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01178502
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2013-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01178502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01178502, "PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01178502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*